| 发布于: | iPhone | 转发：2 | 回复：42 | 喜欢：9 |
The bipartisan legislation you're referring to is the BIOSECURE Act, which aims to prohibit federal contracts, loans, or grants to any Chinese biotechnology company deemed a "company of concern." This includes companies with research agreements with the National Institutes of Health (NIH) or those selling to the Department of Veterans Affairs (VA) or the Department of Defense (DoD), including TRICARE oai_citation:1,Congress Sets Sights on Limiting Access to Chinese Biotech Companies oai_citation:2,The BIOSECURE Act and Its Potential Implications | Insights & Resources | Goodwin oai_citation:3,New bills sound alarms on foreign adversaries and medical diagnostics | LabPulse.com.The legislation specifically targets companies like WuXi AppTec and BGI Genomics, which are linked to the Chinese government and military, to prevent them from accessing U.S. taxpayer dollars. However, reimbursements such as Medicare and Medicaid payments are not considered federal contracts, so they would not be affected by this legislation oai_citation:4,Congress Sets Sights on Limiting Access to Chinese Biotech Companies oai_citation:5,Marshall, Peters, Hagerty, Gallagher & Krishnamoorthi Introduce Bipartisan Legislation To Protect American Genetic Data From Foreign Adversaries - Senator Roger Marshall.The bill includes a waiver mechanism that allows the head of a federal agency to waive the prohibition for up to one year if necessary to support the agency's mission and if it's in the U.S. interest oai_citation:6,The BIOSECURE Act and Its Potential Implications | Insights & Resources | Goodwin. The legislation is still under consideration and has not yet been enacted oai_citation:7,Congress Sets Sights on Limiting Access to Chinese Biotech Companies.
The bipartisan legislation you're referring to is the BIOSECURE Act, which aims to prohibit federal contracts, loans, or grants to any Chinese biotechnology company deemed a "company of concern." This includes companies with research agreements with the National Institutes of Health (NIH) or those selling to the Department of Veterans Affairs (VA) or the Department of Defense (DoD), including TRICARE oai_citation:1,Congress Sets Sights on Limiting Access to Chinese Biotech Companies oai_citation:2,The BIOSECURE Act and Its Potential Implications | Insights & Resources | Goodwin oai_citation:3,New bills sound alarms on foreign adversaries and medical diagnostics | LabPulse.com.The legislation specifically targets companies like WuXi AppTec and BGI Genomics, which are linked to the Chinese government and military, to prevent them from accessing U.S. taxpayer dollars. However, reimbursements such as Medicare and Medicaid payments are not considered federal contracts, so they would not be affected by this legislation oai_citation:4,Congress Sets Sights on Limiting Access to Chinese Biotech Companies oai_citation:5,Marshall, Peters, Hagerty, Gallagher & Krishnamoorthi Introduce Bipartisan Legislation To Protect American Genetic Data From Foreign Adversaries - Senator Roger Marshall.The bill includes a waiver mechanism that allows the head of a federal agency to waive the prohibition for up to one year if necessary to support the agency's mission and if it's in the U.S. interest oai_citation:6,The BIOSECURE Act and Its Potential Implications | Insights & Resources | Goodwin. The legislation is still under consideration and has not yet been enacted oai_citation:7,Congress Sets Sights on Limiting Access to Chinese Biotech Companies.
那为啥康德还在跌，
等今晚确认了，那么法案这事就算过去了，通不通过都无所谓了
利空消息，投票结果如何？
如果不影响医保，那就牛逼了
明确不影响联邦医保，法案影响越来越小。
小秘书不懂英文
原文在哪
康德没反应啊